Immutep (ASX:IMM) - Webinar Presentation Company Presentations by Finance News Network February 17, 2023 05:19 PM Marc Voigt - Executive Director and CEO - Immutep (ASX:IMM) is leading the development of immunotherapy for cancer and autoimmune diseases.
